BIIB
Biogen Inc.Company with tickers: BIIB
CIK
875045
CUSIP
09062X103
Shares Outstanding
147,637,117
13F Activity (30d)
685 filings
673 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $2,477,800,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | $319,500,000 | USD | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Basic) | $2.17 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |
| EPS (Diluted) | $2.15 | USD/shares | 2026-03-31 | 10-Q | 2026-04-29 |